Stay updated on Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial
Sign up to get notified when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.

Latest updates to the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3, indicating a new build/version of the page.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page shows a new revision tag: from v3.6.0 to v3.6.2, signaling a newer version of the page software. This reflects maintenance or bug fixes rather than updates to the study content.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page now shows the study is no longer recruiting participants, and new help sections have been added to guide users on reading the study record and joining a study. The Intervention/Treatment header formatting was adjusted and the revision note updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check39 days agoChange DetectedThe page shows a new revision label, changing from v3.5.4 to v3.5.5. This indicates a small update to the page rather than substantive content changes.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision: v3.5.4 updated from v3.5.3, indicating a minor update to the page’s revision history. It does not modify the study details, eligibility criteria, or outcome measures.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page now displays the updated system revision: v3.5.3, replacing the previous v3.5.2. This reflects a routine platform release rather than a change to study content or user-facing features.SummaryDifference0.1%

Stay in the know with updates to Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.